EpEX induces classical EGFR-mediated pathways (i.e., AKT and Erk) but induces Erk1/2 activation to a lesser extent than EGF in HNSCC cell lines, resulting in a mild cell proliferation but no EMT. This evidence concerns the gene MAPK3 and head and neck squamous cell carcinoma.